Treatment of Evans Syndrome in Active Systemic Lupus Erythematosus with Previous or Concomitant Lupus Nephritis

When Evans syndrome arises in a patient with active systemic lupus erythematosus (SLE), particularly in the presence of a previous or concomitant history of lupus nephritis, the clinical context significantly influences the treatment selection.

This protocol addresses the sub-population where Evans syndrome occurs alongside active systemic lupus erythematosus and a previous or concomitant history of lupus nephritis. The coexistence of these conditions makes certain therapeutic approaches more clinically appropriate than standard Evans syndrome management alone.

Treatment approach — partial overview

The approach in this specific setting involves a targeted combination regimen — including an immunosuppressive agent alongside a corticosteroid. The complete structured protocol, including sequencing and clinical targets, is available in full below.

References

If ES occurs in patient with an underlying active SLE with a previous or concomitant history of lupus nephritis, the use of mycophenolate mofetil in combination with prednisone is more relevant.

View source ↗